|
|
| | (5S,12S)-Dihydroxy-(6E,8E,10E,14Z)-eicosatetraenoic acid Basic information |
| Product Name: | (5S,12S)-Dihydroxy-(6E,8E,10E,14Z)-eicosatetraenoic acid | | Synonyms: | 5(S), 12(S)-DIHETE;5(S),12(S)-DIHYDROXYEICOSA-6E,8E,10E,14Z-TETRAENOIC ACID;6-TRANS-12-EPI LEUKOTRIENE B4;6-TRANS-12-EPI-LTB4;6E-12-EPI-LEUKOTRIENE B4;(5S,6E,8E,10E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid;6-trans-12-epi Leukotriene B4 Lipid Maps MS Standard;Delta(6)-trans-12-epi-leukotriene B4 | | CAS: | 71548-19-1 | | MF: | C20H32O4 | | MW: | 336.47 | | EINECS: | | | Product Categories: | | | Mol File: | 71548-19-1.mol |  |
| | (5S,12S)-Dihydroxy-(6E,8E,10E,14Z)-eicosatetraenoic acid Chemical Properties |
| Boiling point | 536.4±50.0 °C(Predicted) | | density | 1.040±0.06 g/cm3(Predicted) | | storage temp. | −20°C | | solubility | DMF: 50 mg/ml; DMSO: 50 mg/ml; Ethanol: 50 mg/ml; PBS pH 7.2: 1 mg/ml | | pka | 4.66±0.10(Predicted) |
| | (5S,12S)-Dihydroxy-(6E,8E,10E,14Z)-eicosatetraenoic acid Usage And Synthesis |
| Uses | 6-trans-12-epi Leukotirene B4 (LTB4) is a non-enzymatic hydrolysis product of LTA4. It was originally isolated from glycogen-induced rabbit peritoneal polymorphonuclear leukocytes (PMNL). 6-trans-12-epi LTB4 is weakly chemotactic for PMNL, with approximately 20 times less potency than LTB4, and has no effect on the aggregation response. | | Uses | 6-trans-12-epi Leukotriene B4 is a product of the non-enzymatic hydrolysis of LTA4. | | Definition | ChEBI: A leukotriene that is the 6-trans,12S-isomer of leukotriene B4. | | IC 50 | Human Endogenous Metabolite |
| | (5S,12S)-Dihydroxy-(6E,8E,10E,14Z)-eicosatetraenoic acid Preparation Products And Raw materials |
|